Skip to content
10-Q

Quarterly Report

PROTALIX BIOTHERAPEUTICS, INC. PLX

0001104659-25-110824

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 80.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 80.81M sh
Shares Diluted Q3 2025 · Sep 30, 2025 78.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 81.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 73.3M sh
Capex Q3 2025 · Sep 30, 2025 $1.24M
Capex Q3 2025 · Sep 30, 2024 $857K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$14.02M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $4.68M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $13.65M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $19.76M
Stockholders Equity Q3 2025 · Sep 30, 2025 $52.91M
Stockholders Equity Q3 2025 · Jun 30, 2025 $49.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 $43.21M
Stockholders Equity Q3 2025 · Sep 30, 2024 $32.44M
Stockholders Equity Q3 2025 · Jun 30, 2024 $28.58M
Stockholders Equity Q3 2025 · Dec 31, 2023 $33.57M
Current Liabilities Q3 2025 · Sep 30, 2025 $21.95M
Current Liabilities Q3 2025 · Dec 31, 2024 $25.62M
Total Liabilities Q3 2025 · Sep 30, 2025 $29.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $30.21M
Current Assets Q3 2025 · Sep 30, 2025 $66.5M
Current Assets Q3 2025 · Dec 31, 2024 $60.08M
Total Assets Q3 2025 · Sep 30, 2025 $82.26M
Total Assets Q3 2025 · Dec 31, 2024 $73.42M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.03
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 $0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.05
Eps Basic Q3 2025 · Sep 30, 2025 $0.03
Eps Basic Q3 2025 · Sep 30, 2025 −$0.01
Eps Basic Q3 2025 · Sep 30, 2024 $0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.05
Sga Expense Q3 2025 · Sep 30, 2025 $2.93M
Sga Expense Q3 2025 · Sep 30, 2025 $8.16M
Sga Expense Q3 2025 · Sep 30, 2024 $2.6M
Sga Expense Q3 2025 · Sep 30, 2024 $9.19M
Rd Expense Q3 2025 · Sep 30, 2025 $4.47M
Rd Expense Q3 2025 · Sep 30, 2025 $13.93M
Rd Expense Q3 2025 · Sep 30, 2024 $3M
Rd Expense Q3 2025 · Sep 30, 2024 $8.85M
Net Income Q3 2025 · Sep 30, 2025 $2.36M
Net Income Q3 2025 · Sep 30, 2025 −$1.1M
Net Income Q3 2025 · Sep 30, 2024 $3.24M
Net Income Q3 2025 · Sep 30, 2024 −$3.56M
Operating Income Q3 2025 · Sep 30, 2025 $2.13M
Operating Income Q3 2025 · Sep 30, 2025 −$842K
Operating Income Q3 2025 · Sep 30, 2024 $3.99M
Operating Income Q3 2025 · Sep 30, 2024 −$3.29M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $8.32M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $22.37M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $8.38M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $20.43M
Revenue Q3 2025 · Sep 30, 2025 $17.85M
Revenue Q3 2025 · Sep 30, 2025 $43.62M
Revenue Q3 2025 · Sep 30, 2024 $17.96M
Revenue Q3 2025 · Sep 30, 2024 $35.18M